[Federal Register: June 30, 2009 (Volume 74, Number 124)]
[Notices]               
[Page 31314-31315]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr30jn09-101]                         

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

 
Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated June 19, 2008, and published in the Federal 
Register on June 27, 2008, (73 FR 36573), Norac Inc., 405 S. Motor 
Avenue, P.O. Box 577, Azusa, California 91702-3232, made application by 
letter to the Drug Enforcement Administration (DEA) for registration as 
a bulk manufacturer of Gamma Hydroxybutyric Acid (2010), a basic class 
of controlled substance listed in schedule I.
    The company plans to manufacture the listed controlled substance in 
bulk for sale to its customers.
    One objection was received; however, the objector is not registered 
with DEA as a bulk manufacturer of Gamma Hydroxybutyric Acid (GHB). DEA 
has determined that the objection received is without merit and does 
not warrant denial of the application. DEA has also determined that the 
Food & Drug Administration does not preclude the sale of GHB to other 
manufacturers for the development of generic GHB products.
    DEA has considered the factors in 21 U.S.C. 823(a) and determined 
that the registration of Norac Inc. to manufacture the listed basic 
class of controlled substance is consistent with the public interest at 
this time. DEA has investigated Norac Inc. to ensure that the company's 
registration is consistent with the public interest. The investigation 
included the inspection and testing of the company's physical security 
systems, verification of the company's compliance with State and local 
laws, and a review of the company's background and history.
    Therefore, pursuant to 21 U.S.C. 823 and in accordance with 21 CFR 
1301.33, the above named company is granted registration as a bulk 
manufacturer of the basic class of controlled substance listed.


[[Page 31315]]


    Dated: June 23, 2009.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. E9-15446 Filed 6-29-09; 8:45 am]

BILLING CODE 4410-09-P